MDC Stock Overview
Designs, manufactures, and supplies medical products and hospital equipment in Italy and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Medica S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €26.60 |
| 52 Week High | €26.80 |
| 52 Week Low | €14.40 |
| Beta | -0.015 |
| 1 Month Change | 0.76% |
| 3 Month Change | 70.51% |
| 1 Year Change | 11.76% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -20.48% |
Recent News & Updates
Risks To Shareholder Returns Are Elevated At These Prices For Medica S.p.A. (BIT:MDC)
Apr 06
Returns On Capital Signal Tricky Times Ahead For Medica (BIT:MDC)
Feb 05Shareholder Returns
| MDC | IT Medical Equipment | IT Market | |
|---|---|---|---|
| 7D | 0.8% | 0.8% | 0.2% |
| 1Y | 11.8% | 6.5% | 22.4% |
Return vs Industry: MDC exceeded the Italian Medical Equipment industry which returned 6.5% over the past year.
Return vs Market: MDC underperformed the Italian Market which returned 22.4% over the past year.
Price Volatility
| MDC volatility | |
|---|---|
| MDC Average Weekly Movement | 11.3% |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in IT Market | 7.9% |
| 10% least volatile stocks in IT Market | 2.8% |
Stable Share Price: MDC's share price has been volatile over the past 3 months.
Volatility Over Time: MDC's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Italian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 696 | Marco Fecondini | www.medica.it |
Medica S.p.A., together with its subsidiaries, designs, manufactures, and supplies medical products and hospital equipment in Italy and internationally. It offers blood purification equipment comprising dialyzers, ultrafilters, HDF on line sets, blood lines, and pediatric dialyzers for dialysis treatment; and critical care CRRT equipment, hemofilters, pediatric filters, C02 removal, apheresis equipment, fractionator for cascade filtration, plasma filters, and leukocyte adsorber. The company also provides Cardiosmart, an integrated system for the treatment of patients affected by congestive heart failure; MediSulfone membrane and Purema hemoconcentrators for cardiosurgery; and VETSmart, a system to perform hemofiltration, dialysis, and plasmafiltration therapies; and ProtSmart.
Medica S.p.A. Fundamentals Summary
| MDC fundamental statistics | |
|---|---|
| Market cap | €112.34m |
| Earnings (TTM) | €2.97m |
| Revenue (TTM) | €81.58m |
37.9x
P/E Ratio1.4x
P/S RatioIs MDC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDC income statement (TTM) | |
|---|---|
| Revenue | €81.58m |
| Cost of Revenue | €49.40m |
| Gross Profit | €32.18m |
| Other Expenses | €29.21m |
| Earnings | €2.97m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.70 |
| Gross Margin | 39.44% |
| Net Profit Margin | 3.64% |
| Debt/Equity Ratio | 48.1% |
How did MDC perform over the long term?
See historical performance and comparison